Utama › Obesiti › Texas › San Antonio
Kajian klinikal Obesiti di San Antonio, TX
40 kajian untuk Obesiti sedang mencari peserta di lokasi dalam dan sekitar San Antonio (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
- Kailera Clinical Site, San Antonio
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Mengambil pesertaFasa 3
- DM Clinical, San Antonio
- The Texas Liver Institute, San Antonio
- Pinnacle Clinical Research, San Antonio
- dan 1 lagi
Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
Mengambil pesertaFasa 1
- Endeavor Clinical Trials, San Antonio
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Mengambil pesertaFasa 3
- Sleep Therapy Research Center, San Antonio
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Mengambil pesertaFasa 3
- VIP Trials, San Antonio
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Mengambil pesertaFasa 3
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Mengambil pesertaFasa 3
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Mengambil pesertaFasa 3
- IMA Clinical Research San Antonio, San Antonio
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Mengambil pesertaFasa 3
- IMA Clinical Research San Antonio, San Antonio
- Endeavor Clinical Trials, San Antonio
- Consano Clinical Research, LLC, Shavano Park · 12 mi jauh
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Mengambil pesertaFasa 3
- Research Site, San Antonio
- Research Site, San Antonio
- Research Site, San Antonio
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Mengambil pesertaFasa 3
- Sleep Therapy Research Center, San Antonio
- Consano Clinical Research, LLC, Shavano Park · 12 mi jauh
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Mengambil pesertaFasa 3
- Bandera Family Health Care, San Antonio
- Consano Clinical Research - Shavano Park, Shavano Park · 12 mi jauh
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Mengambil pesertaFasa 3
- IMA Clinical Research San Antonio, San Antonio
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Mengambil pesertaFasa 3
- VIP Trials, San Antonio
- Endeavor Clinical Trials, San Antonio
- Consano Clinical Research, LLC, Shavano Park · 12 mi jauh
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Mengambil pesertaFasa 2
- Endeavor Clinical Trials, San Antonio
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Mengambil pesertaFasa 3
- AURORA-1 Clinical Site, San Antonio
- AURORA-1 Clinical Site, San Antonio
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Mengambil pesertaFasa 3
- AURORA-2 Clinical Site, San Antonio
- AURORA-2 Clinical Site, San Antonio
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Mengambil pesertaFasa 3
- Pinnacle Clinical Research - San Antonio, San Antonio
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Mengambil pesertaFasa 2
- Consano Clinical Research, LLC, Shavano Park · 12 mi jauh
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Mengambil pesertaFasa 3
- Pinnacle Clinical Research - South San Antonio, San Antonio
- IMA Clinical Research - San Antonio, San Antonio
- Consano Clinical Research, Shavano Park · 12 mi jauh
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Mengambil pesertaFasa 3
- Sleep Therapy Research Center, San Antonio
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Mengambil pesertaFasa 3Sukarelawan sihat dialu-alukan
- ACCOMPLISH-2 Research Site, San Antonio
- ACCOMPLISH-2 Research Site, San Antonio
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Mengambil pesertaFasa 3
- Sleep Therapy Research Center, San Antonio
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Mengambil pesertaFasa 2
- Endeavor Clinical Trials, San Antonio
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Mengambil pesertaFasa 2
- Consano Clinical Research, LLC, Shavano Park · 12 mi jauh
A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
- ICON, San Antonio
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Mengambil pesertaFasa 4
- Texas Dermatology and Laser Specialists, San Antonio
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Mengambil pesertaFasa 3
- Clinical Trials of Texas, San Antonio
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Mengambil pesertaFasa 3
- Kailera Clinical Site, San Antonio
A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
- ICON Early Phase Services, LLC, San Antonio
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Mengambil pesertaFasa 3
- VIP Trials, San Antonio
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Mengambil pesertaFasa 3
- Research Site, San Antonio
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
- ICON Early Phase Services, San Antonio
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Mengambil pesertaFasa 3
- University Hospital, San Antonio
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Mengambil pesertaFasa 3
- ACCOMPLISH-1 Research Site, San Antonio
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
Mengambil pesertaFasa 2
- Flourish Research - San Antonio Medical Trials, San Antonio
- Endeavor Clinical Trials, San Antonio
- Consano Clinical Research, LLC, Shavano Park · 12 mi jauh
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Mengambil pesertaFasa 3
- VIP Trials_San Antonio, San Antonio
Modifying Adiposity Through Behavioral Strategies to Improve COVID-19 Rehabilitation
Mengambil pesertaSukarelawan sihat dialu-alukan
- South Texas Health Care System, San Antonio, TX, San Antonio
A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
Mengambil pesertaFasa 3Sukarelawan sihat dialu-alukan
- Vanda Investigational Site, San Antonio
Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults
Mengambil pesertaFasa 2
- University of Texas Health Science Center at San Antonio, San Antonio
Kajian Obesiti di bandar lain
- Houston, TX43 kajian
- Chicago, IL41 kajian
- New York City, NY40 kajian
- Washington, DC33 kajian
- Orlando, FL31 kajian
- Dallas, TX30 kajian
- Boston, MA28 kajian
- Las Vegas, NV27 kajian
- Miami, FL27 kajian
- Baltimore, MD25 kajian
- Jacksonville, FL25 kajian
- St. Louis, MO25 kajian
Kajian lain di San Antonio
- Kanser Paru-paru Bukan Sel Kecil59 kajian
- Kanser Kolorektal46 kajian
- Kanser Payudara46 kajian
- Kanser Metastatik44 kajian
- Kanser (semua jenis)41 kajian
- Diabetes Jenis 237 kajian
- Berat Badan Berlebihan34 kajian
- Kanser Ovari31 kajian
- Kanser Pankreas31 kajian
- Kanser Prostat28 kajian
- Kanser Endometrium27 kajian
- Kanser Paru-paru26 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.